Navigation Links
Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
Date:11/16/2010

lieves that these statements are based upon reasonable assumptions within the bounds of its knowledge of its business and operations, there are a number of factors that may cause actual results to differ from these statements. For instance there can be no assurance that: (i) the Company will be able to obtain the capital it needs to develop its product candidates or continue as a going concern; (ii) the Company will be able to successfully enroll patients in its clinical trials, including its Phase I clinical trial for the Neo-Urinary Conduit; (iii) patients enrolled in the Company's clinical trials will not experience adverse events related to the Company's product candidates, which could delay clinical trials or cause the Company to terminate the development of a product candidate; (iv) the results of the clinical trial for the Neo-Urinary Conduit will support further development of that product candidate; (v) data from the Company's ongoing preclinical studies will continue to be supportive of advancing its preclinical product candidates; and (vi) the Company will be able to progress its product candidates that are undergoing preclinical testing, including the Neo-Kidney Augment, into clinical trials. For additional factors which could cause actual results to differ from expectations, reference is made to the reports filed by the Company with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. The forward looking statements in this release are made only as of the date hereof and the Company disclaims any intention or responsibility for updating predictions or expectations in this release.


'/>"/>
SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
2. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
3. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
4. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
5. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
6. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
7. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Ohio , Aug. 28, 2014  A ... competition in generics are adding pressure to pharmaceutical, ... resources. Company resources continue to shrink and approval ... This has led companies to look for additional ... commercialization and for keeping approved products on the ...
(Date:8/28/2014)... VIEJO , Kalifornien, 28. August ... hat heute den Start der Patientenrekrutierung ... Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung der ... zur Embolisation von Aneurysmen („WEB") bekanntgegeben. Adam ... of Tennessee, Department of Neurosurgery/Semmes-Murphey Clinic, ...
(Date:8/28/2014)... , Aug. 28, 2014  Sequent Medical, ... enrollment in an Investigational Device Exemption ("IDE") pivotal ... the WEB™ Aneurysm Embolization System ("WEB"). Adam ... Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator of ... the study, treating them with the WEB at ...
Breaking Medicine Technology:4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3
... Medical International Limited (NYSE: MR ), a leading ... its selected unaudited financial results for the first quarter ended ... First Quarter 2011 Net revenues were $180.9 ... 2010. Robust international sales of $108.5 million, a year-over-year ...
... /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... services in China through the operations of United Family Healthcare, ... clinics, today announced financial results for the three month period ... 2011 Financial Highlights Revenue from healthcare ...
Cached Medicine Technology:Mindray Announces First Quarter 2011 Financial Results 2Mindray Announces First Quarter 2011 Financial Results 3Mindray Announces First Quarter 2011 Financial Results 4Mindray Announces First Quarter 2011 Financial Results 5Mindray Announces First Quarter 2011 Financial Results 6Mindray Announces First Quarter 2011 Financial Results 7Mindray Announces First Quarter 2011 Financial Results 8Mindray Announces First Quarter 2011 Financial Results 9Mindray Announces First Quarter 2011 Financial Results 10Mindray Announces First Quarter 2011 Financial Results 11Mindray Announces First Quarter 2011 Financial Results 12Mindray Announces First Quarter 2011 Financial Results 13Mindray Announces First Quarter 2011 Financial Results 14Chindex International, Inc. Reports First Quarter 2011 Financial Results 2Chindex International, Inc. Reports First Quarter 2011 Financial Results 3Chindex International, Inc. Reports First Quarter 2011 Financial Results 4Chindex International, Inc. Reports First Quarter 2011 Financial Results 5Chindex International, Inc. Reports First Quarter 2011 Financial Results 6Chindex International, Inc. Reports First Quarter 2011 Financial Results 7Chindex International, Inc. Reports First Quarter 2011 Financial Results 8Chindex International, Inc. Reports First Quarter 2011 Financial Results 9Chindex International, Inc. Reports First Quarter 2011 Financial Results 10
(Date:8/28/2014)... 28, 2014 AmeriPride Services, a leading ... announced the launch of its new Customer Portal, an ... easier and more convenient for customers. The industry-leading digital ... better communicate with the company. , Features of the ... Access, download and pay bills online , ...
(Date:8/28/2014)... 2014 Clarity PSO , an ... as a federal Patient Safety Organization (PSO) for another ... Healthcare Research and Quality (AHRQ). Clarity PSO will continue ... services following the true intentions of the Patient Safety ... are proud and eager to continue our journey as ...
(Date:8/28/2014)... 2014 Genetic testing for multiple ... world, with large reference laboratories as well as ... with regard to the genetic variants analyzed, the ... struggle to find the most appropriate laboratory providers ... sort through these differences, Hayes, Inc. has added ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 veEDIS ... Emergency Department Information System (EDIS), in Lawrence Medical ... nurses and physicians to document patient care, veEDIS ... patient record-keeping, as well as the authorized, confidential ... Through the veEDIS technology, designed in accordance ...
(Date:8/28/2014)... Altec Products, Inc., a leader ... today that they have been awarded the “Partnering ... the International Association of Microsoft Channel Partners (IAMCP) ... in 1994, providing Microsoft Partners with a voice ... at large while facilitating mutual growth and business ...
Breaking Medicine News(10 mins):Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3
... of patients whose myelodysplastic syndrome is related to earlier ... have a poor prognosis, researchers from The University of ... Annual Meeting of the American Society of Hematology. ... or both treatments are usually told that they have ...
... of biological macromolecules are the central bases of ... cells by linking many small molecules together. Naturally ... A detailed understanding of the synthesis of these ... for understanding biological systems, and for the development ...
... smells apart is no problem for the human nose. How ... by an interdisciplinary team of researchers at the RUB. The ... of the three-dimensional structure of the binding site of an ... pattern of hydrogen bonds between odorant and receptor, which accounts ...
... News) -- Undiagnosed chronic fatigue syndrome may account for up ... for extended periods of time and are not truant or ... out of school, a new study reveals. For the ... 16 at three secondary schools in England and concluded that ...
... US Prostate Cancer Prevention Trial found cancer in many men ... which PSA level should lead to a biopsy recommendation. ... considerable controversy, that the evidence does not support recommending PSA ... the risks outweigh the benefits. Now, a study shows ...
... - Adding a drug that activates genes to frontline combination ... remission rate after initial treatment, researchers at The University of ... Meeting of the American Society of Hematology. Results of ... stage for a national Phase III clinical trial of the ...
Cached Medicine News:Health News:Prognostic model developed for MDS related to prior cancer therapy 2Health News:Prognostic model developed for MDS related to prior cancer therapy 3Health News:Visualization of DNA synthesis in vivo 2Health News:A good nose: RUB-Researchers decipher interaction of fragrances and olfactory receptors 2Health News:Chronic Fatigue Tied to Extended School Absences 2Health News:Biopsy referral after PSA screening stays consistent over time 2Health News:AML patients have high response rate with vorinostat added to treatment 2
HbA1c / HbCalibrator...
Heparin-Platelet Factor 4 Induced Antibody...
Multi-constituent Calibration Plasma for Functional Assays of Coagulation Parameters on STA© Analyzers....
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
Medicine Products: